UM  > Faculty of Health Sciences  > DEPARTMENT OF BIOMEDICAL SCIENCES
Status已發表Published
Alteration of electrostatic surface potential enhances affinity and tumor killing properties of anti-ganglioside GD2 monoclonal antibody hu3F8
Zhao, Q.; Ahmed, M.; Guo, H.; Cheung, I.; Cheung, N.
2015-05-22
Source PublicationJournal of Biological Chemistry
ISSN0021-9258
Pages13017-13027
AbstractGanglioside GD2 is highly expressed on neuroectodermal tumors and an attractive therapeutic target for antibodies that have already shown some clinical efficacy. To further improve the current antibodies, which have modest affinity, we sought to improve affinity by using a combined method of random mutagenesis and in silico assisted design to affinity-mature the anti-GD2 monoclonal antibody hu3F8. Using yeast display, mutants in the Fv with enhanced binding over the parental clone were FACS-sorted and cloned. In silico modeling identified the minimal key interacting residues involved in the important charged interactions with the sialic acid groups of GD2. Two mutations, D32H (L-CDR1) and E1K (L-FR1) altered the electrostatic surface potential of the antigen binding site, allowing for an increase in positive charge to enhance the interaction with the negatively charged GD2-pentasaccharide headgroup. Purified scFv and IgG mutant forms were then tested for antigen specificity by ELISA, for tissue specificity by immunohistochemistry, for affinity by BIACORE, for antibody-dependent cell-mediated cytotoxicity (ADCC) and complement-mediated cytotoxicity in vitro, and for anti-tumor efficacy in xenografted humanized mice. The nearly 7-fold improvement in affinity of hu3F8 with a single D32H (L-CDR1) mutation translated into a ∼12-fold improvement in NK92MI-transfected CD16-mediated ADCC, a 6-fold improvement in CD32-mediated ADCC, and a 2.5-fold improvement in complement-mediated cytotoxicity while maintaining restricted normal tissue cross-reactivity and achieving substantial improvement in tumor ablation in vivo. Despite increasing GD2 affinity, the double mutation D32H (L-CDR1) and E1K (L-FR1) did not further improve anti-tumor efficacy.
Keywordantibody engineering cancer therapy electrostatics ganglioside immunotherapy
URLView the original
Language英語English
The Source to ArticlePB_Publication
PUB ID55326
Document TypeJournal article
CollectionDEPARTMENT OF BIOMEDICAL SCIENCES
Corresponding AuthorCheung, N.
Recommended Citation
GB/T 7714
Zhao, Q.,Ahmed, M.,Guo, H.,et al. Alteration of electrostatic surface potential enhances affinity and tumor killing properties of anti-ganglioside GD2 monoclonal antibody hu3F8[J]. Journal of Biological Chemistry, 2015, 13017-13027.
APA Zhao, Q.., Ahmed, M.., Guo, H.., Cheung, I.., & Cheung, N. (2015). Alteration of electrostatic surface potential enhances affinity and tumor killing properties of anti-ganglioside GD2 monoclonal antibody hu3F8. Journal of Biological Chemistry, 13017-13027.
MLA Zhao, Q.,et al."Alteration of electrostatic surface potential enhances affinity and tumor killing properties of anti-ganglioside GD2 monoclonal antibody hu3F8".Journal of Biological Chemistry (2015):13017-13027.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Zhao, Q.]'s Articles
[Ahmed, M.]'s Articles
[Guo, H.]'s Articles
Baidu academic
Similar articles in Baidu academic
[Zhao, Q.]'s Articles
[Ahmed, M.]'s Articles
[Guo, H.]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Zhao, Q.]'s Articles
[Ahmed, M.]'s Articles
[Guo, H.]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.